ImmunoGen Message Board - Msg: 33706492

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	2/13/2022 1:12:09 AM
	Read Replies (1) of 5665

IMGN receives an Outperform rating, target $18. thefly.com I believe the Annual Report due late this month may announce the filing of the BLA, approval could come in the third quarter. A partnership could come at any time, and that could take the stock well above the $18 figure. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next